GEOGRAPHIC ATROPHY
Clinical trials for GEOGRAPHIC ATROPHY explained in plain language.
Never miss a new study
Get alerted when new GEOGRAPHIC ATROPHY trials appear
Sign up with your email to follow new studies for GEOGRAPHIC ATROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to slow vision loss from dry macular degeneration
Disease control Not yet recruitingThis study tests an oral drug called STL303 for geographic atrophy, a form of dry age-related macular degeneration that causes a blind spot in central vision. About 300 adults aged 60 and older will receive either STL303 or a placebo pill for up to 2 years. The goal is to see if …
Matched conditions: GEOGRAPHIC ATROPHY
Phase: PHASE2 • Sponsor: Sitala Bio LTD • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Gene therapy injection aims to halt blinding eye disease
Disease control Not yet recruitingThis early-stage trial tests a gene therapy called AGX-08 for geographic atrophy, an advanced form of age-related macular degeneration that causes vision loss. The study will involve 24 people aged 50 and older, each receiving a single injection into one eye. The main goal is to …
Matched conditions: GEOGRAPHIC ATROPHY
Phase: EARLY_PHASE1 • Sponsor: Zhongmou Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Could zapping a nerve in your face save your sight?
Disease control Not yet recruitingThis early study tests whether stimulating a nerve cluster behind the cheekbone (the pterygopalatine ganglion) is safe and doable for people with geographic atrophy, a severe form of age-related macular degeneration that causes blind spots. Sixty-two adults will receive either re…
Matched conditions: GEOGRAPHIC ATROPHY
Phase: NA • Sponsor: Shanghai Institute of Acupuncture, Moxibustion and Meridian • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New eye scanner could spot hidden signs of blindness
Diagnosis Not yet recruitingThis study will test a new, non-invasive eye scanner called wide field OCTA in 200 people with various eye diseases, including age-related macular degeneration, diabetic retinopathy, and dry eye. The goal is to see if this device can provide better images of blood vessels in the …
Matched conditions: GEOGRAPHIC ATROPHY
Sponsor: IRCCS San Raffaele • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
Virtual reality could revolutionize how we measure vision loss
Knowledge-focused Not yet recruitingThis study aims to see if virtual reality tests can better measure how age-related macular degeneration affects daily life compared to standard eye exams. Researchers will enroll 60 participants, including healthy adults and those with the eye condition. The goal is to develop a …
Matched conditions: GEOGRAPHIC ATROPHY
Phase: NA • Sponsor: Streetlab • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC